Dako A/S (Acquired by Agilent Technologies, Inc.) (A) to Offer New Antibody in U.S. to Diagnose Breast Cancer
4/3/2013 10:22:22 AM
More...
|
FDA Approves Two Dako A/S (Acquired by Agilent Technologies, Inc.) (A) Assays as Companion Diagnostics for Genentech (RHHBY)'s Breast Cancer Medicine
3/5/2013 7:11:55 AM
More...
|
Panagene Signs Off With Dako A/S (Acquired by Agilent Technologies, Inc.) (A) to Supply PNA Oligomer Component
2/22/2013 10:03:21 AM
More...
|
Dako A/S (Acquired by Agilent Technologies, Inc.) (A) Receives FDA Approval for Fast, Accurate, Nontoxic FISH Assay for Cancer Diagnostics
2/15/2013 7:12:29 AM
More...
|
Dako A/S (Acquired by Agilent Technologies, Inc.) (A) to Collaborate With Pfizer Inc. (PFE) on Companion Diagnostics
2/12/2013 9:18:52 AM
More...
|
Dako A/S (Acquired by Agilent Technologies, Inc.) (A) Enters Collaboration With Eli Lilly and Company (LLY) for Development of Companion Diagnostics
1/7/2013 9:45:13 AM
More...
|
Agilent Technologies, Inc. (Santa Clara, California) (A) Completes Acquisition of Dako, Danish Cancer Diagnostics Company
6/21/2012 11:00:54 AM
More...
|
FDA Approves Dako A/S's HercepTest(TM) and HER2 FISH pharmDx(TM) Kit as Companion Diagnostics for Genentech (RHHBY)'s New Cancer Drug Perjeta(TM)
6/12/2012 8:08:26 AM
More...
|
Van Andel Institute and Dako A/S Sign Agreement to License Cancer Diagnostic Tool
5/17/2012 10:30:33 AM
More...
|
Dako A/S, Genentech (RHHBY) Ink Pact on the FDA Regulatory Submissions of Dako's HercepTest(TM) and HER2 FISH pharmDx(TM) as Companion Diagnostics for Trastuzumab Emtansine (T-DM1)
5/1/2012 7:31:15 AM
More...
|
|